Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ANGO
#2548
AngioDynamics, Inc.
11.440
0
+1.33%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+1.33%
Changement Mensuel
+12.16%
Evolution sur 6 mois
-7.59%
Changement Annuel
-7.59%
Clôture Précédente
11.290
0
Open
11.440
0
Bid
Ask
Low
11.440
0
High
11.440
0
Volume
48
Marchés
Actions des Marchés US
Soins de Santé
ANGO
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
38.44 M
38.97 M
39.67 M
40.28 M
40.63 M
—
Valuation ratios
Enterprise value
854.89 M
736.16 M
330.67 M
178.09 M
338.26 M
1.56 B
Price to earnings ratio
-28.65
-28.87
-7.11
-1.37
-11.69
-53.47
Price to sales ratio
3.09
2.42
1.1
0.83
1.35
5.84
Price to cash flow ratio
37.38
-106.44
4 788.26
-9
-39.13
-206.07
Price to book ratio
2.05
1.8
0.99
1.23
2.17
3.97
Enterprise value to EBITDA ratio
-74.45
-536.95
-16.15
-0.81
-20.94
-87.57
Profitability ratios
Return on assets %
0.06
0.05
0.1
0.58
0.12
0.1
Return on equity %
0.07
0.06
0.14
0.9
0.19
0.15
Return on invested capital %
26.01
27.59
48.12
273.77
100.56
78.77
Gross margin %
53.88
52.41
51.44
50.9
53.92
218.3
Operating margin %
12.12
9
15.11
63.32
13.66
42.86
EBITDA margin %
-3.95
-0.43
-6.05
-72.14
-5.52
-19.56
Net margin %
10.84
8.4
15.48
60.66
11.62
36.06
Liquidity ratios
Quick ratio
1.6
1.24
1.29
1.46
1.4
5.51
Current ratio
2.45
1.93
1.95
2.12
2.21
8.95
Inventory turnover
2.47
3.01
3.08
2.57
2.2
2.21
Asset turnover
0.5
0.57
0.62
0.71
0.98
1.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.04
0.05
0.09
0
—
—
Long term debt to total equity ratio
0.05
0.06
0.13
0
—
—
Per share metrics
Operating cash flow per share
0.63
0.18
0
0.7
0.25
0.14
EBIT per share
-0.92
-0.73
-1.3
-6.15
-0.98
-0.79
EBITDA per share
-0.3
-0.04
-0.52
-5.46
-0.4
-0.35
Total debt per share
—
—
—
—
—
—
Cash per share
1.26
0.74
1.13
1.89
1.37
4.41
Net current asset value per share
3.67
3.67
4.14
4.81
4.12
16.03
Tangible book value per share
1.8
1.82
2.73
3.19
2.79
10.92
Working capital per share
2.17
1.77
2.02
2.54
2.26
8.86
Book value per share
11.46
10.88
9.58
5.12
4.48
17.62
Nouvelles
Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises
XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation
AngioDynamics élargit les indications européennes du système NanoKnife
AngioDynamics expands European indications for NanoKnife system
Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings
Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect?
AngioDynamics (ANGO) Down 3.9% Since Last Earnings Report: Can It Rebound?
Here's Why You Should Add Masimo Stock to Your Portfolio Now